Search results
AstraZeneca's COVID prevention drug application gets EU fast-track assessment
Reuters via Yahoo Singapore Finance· 4 hours ago"The EMA's (European Medicines Agency) Committee for Medicinal Products for Human Use(CHMP) granted...
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Zacks via Yahoo Singapore Finance· 5 days agoData from a late-stage study shows that treatment with AstraZeneca's (AZN) Imfinzi plus chemotherapy...
AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung...
Benzinga via Yahoo Singapore Finance· 6 days agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) released topline data from the ADJUVANT BR.31 Phase 3...
China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
Reuters via Yahoo Singapore Finance· 5 days agoAstraZeneca said the approval by China's National Medical Products Administration (NMPA) was based...
China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer...
Benzinga via Yahoo Singapore Finance· 5 days agoOn Wednesday, China approved AstraZeneca plc's (NYSE:AZN) Tagrisso (osimertinib) with the addition...
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Zacks via Yahoo Singapore Finance· 3 days agoThis Score examines things like projected and historical earnings, sales, and cash flow to find...
AstraZeneca's Imfinzi fails in late-stage trial to treat certain lung cancers
Reuters via Yahoo Singapore Finance· 6 days agoImfinzi is a human monoclonal antibody, which works to block a tumour's ability to evade and dampen...
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Zacks via Yahoo Singapore Finance· 3 days agoThis week, the FDA rejected Merck's MRK and AbbVie’s ABBV regulatory filings seeking approvals for...
3 Healthcare Mutual Funds Thriving Amid Economic Shifts
Zacks via Yahoo Singapore Finance· 5 days agoHealthcare mutual funds such as FPHAX, VGHCX and PHSTX are increasingly favored as solid investments...
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo Singapore Finance· 5 days agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...